SCHEMBL6858741

SCHEMBL6858741

COc1ccc(N)cc1-c1ccc(/C=C2/N=C(N)N(C)C2=O)o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 2/20 0.41
▸ CLK2 P49760 2/20 0.41
▸ DYRK2 Q92630 2/20 0.41
▸ GSK3A P49840 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ DYRK3 O43781 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ LTB4R Q15722 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ DYRK4 Q9NR20 1/20 0.41
▸ DYRK1B Q9Y463 1/20 0.41
▸ MAPT P10636 8/20 0.40
▸ MEN1 O00255 7/20 0.40
▸ KMT2A Q03164 7/20 0.40
▸ HPGD P15428 6/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ RECQL P46063 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ PKM P14618 3/20 0.40
▸ GLA P06280 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6859235 0.87 PIK3CG (0.40) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1116042 0.87 PIK3CG (0.40) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1116044 0.87 PIK3CG (0.40) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1116039 0.84 MAPT (0.41) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1116038 0.84 MAPT (0.41) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1228111 0.81 HTRA2 (0.55) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1228108 0.81 HTRA2 (0.55) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1116259 0.78 CLK1 (0.38) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1116258 0.78 CLK1 (0.38) CLK1CLK2DYRK2GSK3AGSK3B
SCHEMBL1115930 0.72 MAPT (0.51) CLK1CLK2DYRK2GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback